Centaurus Financial Inc. Decreases Stock Holdings in CVS Health Co. (NYSE:CVS)

Centaurus Financial Inc. lowered its position in shares of CVS Health Co. (NYSE:CVS) by 8.0% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,149 shares of the pharmacy operator’s stock after selling 534 shares during the period. Centaurus Financial Inc.’s holdings in CVS Health were worth $387,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the third quarter worth about $25,000. Livelsberger Financial Advisory purchased a new stake in CVS Health in the 3rd quarter worth approximately $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health during the third quarter valued at approximately $32,000. First Community Trust NA raised its holdings in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in CVS Health in the third quarter worth $33,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 1.8 %

Shares of NYSE CVS opened at $59.02 on Wednesday. The firm’s 50 day moving average price is $59.26 and its 200-day moving average price is $58.69. CVS Health Co. has a 52-week low of $52.71 and a 52-week high of $83.25. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company has a market cap of $74.27 billion, a PE ratio of 14.98, a P/E/G ratio of 0.98 and a beta of 0.55.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same period in the prior year, the firm posted $2.21 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. On average, equities research analysts expect that CVS Health Co. will post 5.43 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.51%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 67.51%.

Analysts Set New Price Targets

CVS has been the subject of several research analyst reports. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Barclays lowered their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a report on Thursday, November 7th. TD Cowen increased their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday. UBS Group lifted their price target on CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. Finally, Piper Sandler decreased their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a report on Monday. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $70.33.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.